Chemical Structure (Image 1)
Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 0093-7704
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 0093-7704). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Tenofovir Fumurate Chemical Structure (Image 2)
1 (Image 3)
This is a medicine packaging label, indicating that the package contains 30 tablets of a drug called Emtricitabine and Tenofovir Disoproxil Fumarate. The label also includes a National Drug Code (NDC) and a serialization coding area. The instruction to dispense the accompanying medication guide is provided to the pharmacist.*
Image 4
This is a description of a medication called "Disoproxil Fumarate Emtricitabine and Tablets Tenofovir". Each film-coated tablet contains 200mg Emtricitabine and 300mg Tenofovir Disoproxil Fumarate equivalent to 245mg Tenofovir Disoproxi. The usual dosage is mentioned in the package insert, and the medication should be kept at 20-25°C (68-77°F) in a controlled room temperature. It's important to keep out of the reach of children and should only be dispensed in the original container. The medicine is manufactured by Pliva Hrvatska d.o.o in Croatia and manufactured for Teva Pharmaceuticals USA, Inc. Pharmacist must dispense the accompanying medication guide for each patient. However, there is no information about the uses, side effects or precautions of the medicine.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
